CLINICAL_TRIALS
trial_result
· 2020-10-12
Clinical Trial Update: Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease [Phase 3]
Summary
Phase 3 safety study of DS-5565 for fibromyalgia in patients with chronic kidney disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2020-10-12